The scientific class of CLL is very heterogeneous, starting from a fairly asymptomatic illness that could even regress spontaneously to some progressive illness that ultimately leads to the patient’s death, so there has normally been extraordinary fascination in identifying the prognosis of person patients. Even though lots of prognostic markers